Search results
This user guide provides information about the purpose of the CancerStats2 (CS2) data platform, an overview of what data and interactive reports are available and how the data should be used.
Guidance on using the Rapid Cancer Registration Data (RCRD) to measure progress against the 75% staging ambition.
The National Disease Registration Service (NDRS) undertakes analysis to understand the impact of comorbidities on cancer patients.
The National Disease Registration Service (NDRS) carries out analysis to understand and monitor variation in cancer diagnostic pathways.
The British Association of Dermatologists (BAD) and the National Disease Registry Service (NDRS) partnership is a collaborative and multidisciplinary team with clinical, epidemiological, and analytical expertise. Using the high-quality national skin cancer data, the partnership aims to support patient...
Find out more about the National Cancer Registration and Analysis Service (NCRAS) - one of the 2 disease registration services within the National Disease Registration Service (NDRS)
This document provides guidance to clinicians reporting regimen outcomes for non-curative treatments in the systemic anti-cancer therapy (SACT) data set.